NYSE:MCKMcKesson Stock Price, Forecast & News

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MCK stock has increased by 12.7% and is now trading at $152.34.
View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson.

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for McKesson.

McKesson Co. (NYSE:MCK) announced its quarterly earnings results on Monday, August, 3rd. The company reported $2.77 earnings per share for the quarter, topping analysts' consensus estimates of $2.35 by $0.42. The firm earned $55.68 billion during the quarter, compared to analysts' expectations of $54.16 billion. McKesson had a return on equity of 42.33% and a net margin of 0.40%. The firm's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.31 EPS.
View McKesson's earnings history.

McKesson declared a quarterly dividend on Wednesday, July 29th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.42 per share on Thursday, October 1st. This represents a $1.68 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend is Monday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.41.
View McKesson's dividend history.

McKesson issued an update on its FY21 earnings guidance on Monday, August, 3rd. The company provided earnings per share guidance of $14.70-15.50 for the period, compared to the Thomson Reuters consensus estimate of $14.39.

14 equities research analysts have issued 12-month price objectives for McKesson's shares. Their forecasts range from $147.00 to $204.00. On average, they expect McKesson's stock price to reach $179.08 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price.
View analysts' price targets for McKesson.

News coverage about MCK stock has been trending very positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. McKesson earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.
View the latest news about McKesson.

McKesson saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 2,420,000 shares, a decrease of 5.1% from the July 15th total of 2,550,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.5% of the shares of the company are short sold.
View McKesson's Short Interest.

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), CVS Health (CVS), salesforce.com (CRM), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Allergan (AGN), Bank of America (BAC), AbbVie (ABBV) and Chevron (CVX).

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pzena Investment Management LLC (1.85%), LSV Asset Management (1.00%), Scharf Investments LLC (0.55%), Sumitomo Mitsui Trust Holdings Inc. (0.45%), Swiss National Bank (0.39%) and New York State Common Retirement Fund (0.28%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy.
View institutional ownership trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including Prudential PLC, Pzena Investment Management LLC, Morningstar Investment Services LLC, MERIAN GLOBAL INVESTORS UK Ltd, BNP PARIBAS ASSET MANAGEMENT Holding S.A., SG Americas Securities LLC, New York State Common Retirement Fund, and Wedge Capital Management L L P NC. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, and Sundeep G Reddy.
View insider buying and selling activity for McKesson.

MCK stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, Mackay Shields LLC, Strs Ohio, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Pendal Group Ltd, Raymond James Financial Services Advisors Inc., and Railway Pension Investments Ltd.
View insider buying and selling activity for McKesson.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MCK stock can currently be purchased for approximately $152.34.

McKesson has a market capitalization of $24.71 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

The official website for McKesson is www.mckesson.com.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]